World & BusinessSenate Democrats renew demand for Trump’s drug-price contracts
The Washington Post reports that lawmakers say they cannot judge the administration’s drug-price initiative until the contracts are released.
TLDR
The Washington Post reports that Senate Democrats are again demanding the release of contracts Trump administration officials negotiated with more than two dozen pharmaceutical companies to lower drug prices. Lawmakers say they cannot judge the initiative’s effectiveness until the contracts are released. The newspaper says it has published portions of the contracts with Pfizer and Eli Lilly.
Senate Democrats renew demand for Trump’s drug-price contracts
The Washington Post reports that lawmakers say they cannot judge the administration’s drug-price initiative until the contracts are released.
TLDR
The Washington Post reports that Senate Democrats are again demanding the release of contracts Trump administration officials negotiated with more than two dozen pharmaceutical companies to lower drug prices. Lawmakers say they cannot judge the initiative’s effectiveness until the contracts are released. The newspaper says it has published portions of the contracts with Pfizer and Eli Lilly.
